Test Material:	Ethalfluralin

49385902

Validation of an Analytical Method for the Determination of
Ethalfluralin in Water

49385903

Independent Laboratory Validation of an Analytical Method for the
Determination of Ethalfluralin in Water by Gas Chromatography with
Electron-impact Mass Spectrometry Detection (GC/MS)

EPA PC Code:	113101

OCSPP Guideline: 850 6100

For CDM Smith

Primary Reviewer: Lisa Muto	Signature:

Date: 1/9/15

Secondary Reviewer: Lynne Binari	Signature:

Date: 1/9/15

QC/QA Manager: Joan Gaidos	Signature:

Date: 1/9/15

MRU):

Title:
MRU):

Title:



u/rfmC^ LJ) CZaj




-------
Ethalfluralin (PC 113101)

MRIDs 49385902 (ECM) 49385903 (ILV)

Analytical method for ethalfluralin in drinking, surface and ground water

Reports:

Document No.

Guideline:

Statements:

Classification:

PC Code:
Reviewer:

Reviewer:

ECM: EPAMRID No. 49385902. Betson, S. 2012. Validation of an
Analytical Method for the Determination of Ethalfluralin in Water. Dow
AgroSciences Study Reference No.: 120814. CEMAS Study No.: CEMS-
5608. Report prepared by CEM Analytical Services (CEMAS), Berkshire,
United Kingdom, sponsored and submitted by Regulatory Sciences and
Government Affairs- Indianapolis Lab, Dow AgroSciences LLC,
Indianapolis, Indiana; 123 pages. Final report issued December 21, 2012.
ILV: EPAMRID 49385903. Amic, S. 2013. Independent Laboratory
Validation of an Analytical Method for the Determination of Ethalfluralin in
Water by Gas Chromatography with Electron-impact Mass Spectrometry
Detection (GC/MS). Dow AgroSciences Study Reference No.: 130633. EAS
Chem SAS Study No.: S13-01932. Report prepared by Eurofins Agroscience
Services Chem SAS, Vergeze, France, sponsored and submitted by
Regulatory Sciences and Government Affairs- Indianapolis Lab, Dow
AgroSciences LLC, Indianapolis, Indiana; 71 pages. Final report issued
October 4, 2013.

MRIDs 49385902 & 49385903
850.6100

ECM: The study was conducted in accordance with OECD and UK Good
Laboratory Practices (GLP; p. 3; Appendix C, p. 123). Signed and dated No
Data Confidentiality, GLP and Quality Assurance statements were included
(pp. 2-4). An authenticity statement was not included; however, a signature
page was included (p. 5).

ILV: The study was conducted in accordance with OECD GLP (p. 3).

Signed and dated No Data Confidentiality, GLP and Quality Assurance
statements were included (pp. 2-4). A statement of the authenticity of the
study report was included as part of the Quality Assurance Statement (p. 4).
A signature page was also included (p. 5).

This analytical method is classified as Acceptable. Representative
chromatograms in the ECM and ILV were faint and difficult to interpret. It
will be helpful if clear copies are provided by the registrant.

113101

Patricia Engel	Signature:

Physical Scientist	Date: 10/16/2018

Mohammed Ruhman	Signature:

Ph.D., Senior Scientist	Date: 10/16/2018

Executive Summary

The analytical method, Dow AgroSciences Study Reference No. 120814, is designed for the
quantitative determination of ethalfluralin in ground, surface and drinking water at the LOQ of
5.0 ng/L using GC/MS. The LOQ is less than the current lowest toxicological level of concern in

Page 2 of 11


-------
Ethalfluralin (PC 113101)

MRIDs 49385902 (ECM) 49385903 (ILV)

water. The ILV was successful in the first trial. The supporting chromatograms were
decipherable, but not clearly readable with normal, expected resolution.

Table 1. Analytical Method Summary

Analyte(s)
by Pesticide

MRID

EPA
Review

Matrix

Method Date

(dd/mm/yyyy)

Registrant

Analysis

Limit of
Quantitation
(LOQ)

Environmental
Chemistry
Method

Independent
Laboratory
Validation

Ethalfluralin

49385902

49385903



Drinking,
Surface

and
Ground
Water

21/12/2012

Dow
AgroSciences
LLC

GC/MS

5.0 ng/L

I. Principle of the Method

Samples (500 mL) were mixed with 4 mL of methanol then fortified as necessary (pp. 16, 19 of
MRID 49385902). Samples were manually mixed then left to stand for 5 minutes. The mixture
was purified using a Strata CI8 solid phase extraction (SPE) cartridge (500 mg, 6 mL). The SPE
cartridge was conditioned with ethyl acetate, methanol and ultrapure water (4 mL each). The
extract was applied then the analyte was eluted with ethyl acetate (6 mL) without vacuum
initially. The eluate was reduced under a stream of nitrogen with a Techne Dri-block
concentrator (temperature not specified; p. 20 of MRID 49385902). The residue was
reconstituted in 1 mL of ethyl acetate prior to GC/MS analysis.

Samples were analyzed for ethalfluralin by gas chromatography (Agilent Model 6890A gas
chromatograph) using a Durabond-5MS, 30 m x 0.25 mm, 0.25-|am column (initial oven
temperature 100°C) with electron impact tandem mass spectrometry (splitless mode; carrier gas,
helium; pp. 20-21 of MRID 49385902). Injection volume was not specified. Ions monitored were
in z 276 (quantitation ion), in z 292 (confirmation ion 1) and in z 316 (confirmation ion 2). The
relative ratios of the three transitions were quantified for confirmation of ethalfluralin (p. 23 of
MRID 49385902).

In the ILV, the extraction procedure and GC/MS analysis was performed according to the ECM,
without modification (pp. 14-16 of MRID 49385903). The only noted differences were the
specification of the evaporation temperature (room temperature) and GC/MS injection volume of
4 |iL.

In the ECM and ILV, the Limit of Quantification (LOQ) and Limit of Detection (LOD) were 5
ng/L and 1.5 ng/L, respectively (p. 26 of MRID 49385902; p. 11; Tables 1-18, pp. 24-35 of
MRID 49385903).

Page 3 of 11


-------
Ethalfluralin (PC 113101)

MRIDs 49385902 (ECM) 49385903 QLV)

II. Recovery Findings

ECM (MRID 49385902): Mean recoveries and relative standard deviations (RSD) were within
requirements (mean 70-120%; RSD <20%) for analysis of ethalfluralin in drinking, ground and
surface waters at the LOQ and lOxLOQ (p. 24; Tables 1-12, pp. 30-40). One sample per matrix
was also dosed at the LOD. Confirmation of the identified peaks was based on the observation of
its three parent-to-daughter ion transitions and the quantification of the relative ratios of those
transitions. The water matrices were fully characterized at CEMAS (pp. 13-16). The drinking
water was obtained from the test facility (CEMAS). The ground water was obtained from a well
near Henley-on-Thames, United Kingdom. The surface water was obtained from the Cut River,
Bracknell, United Kingdom.

ILV (MRID 49385903): Mean recoveries and relative standard deviations (RSD) were within
requirements (mean 70-120%; RSD <20%) for analysis of ethalfluralin in drinking, ground and
surface waters at the LOQ and lOxLOQ (pp. 18-19; Tables 1-18, pp. 24-35). One sample per
matrix was also dosed at the LOD. Confirmation of the identified peaks was based on the
observation of its three parent-to-daughter ion transitions and the quantification of the relative
ratios of those transitions. The water matrices were fully characterized at Eurofins IPL Sud,
Vergeze, France (non-GLP facility; ISO certified facility; p. 12). The drinking water was
obtained from a tap in Vergeze, France. The ground water was obtained from Evian, France. The
surface water was obtained from Rhony, Gard, France. The method validation was successful on
the first trial (p. 18).

Page 4 of 11


-------
Ethalfluralin (PC 113101)

MRIDs 49385902 (ECM) 49385903 (ILV)

Table 2. Initial Validation Method Recoveries for Ethalfluralin in Water1

Analyte

Fortification
Level (ng/L)

Number
of Tests

Recovery
Range (%)

Mean
Recovery (%)

Standard
Deviation (%)

Relative Standard
Deviation (%)

Drinking Water

m/z 276 (quantitation ion)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

72-107

83

14.0

16.9



50

5

75-115

87

16.3

18.6

m/z 292 (confirmation ion 1)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

77-94

86

7.4

8.6



50

5

75-114

87

15.7

17.9

m/z 316 (confirmation ion 2)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

69-106

86

13.5

15.8



50

5

75-118

88

17.5

19.8

Ground Water

m/z 276 (quantitation ion)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

74-92

82

7.6

9.3



50

5

65-103

85

16.3

19.2

m/z 292 (confirmation ion 1)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

76-95

85

7.1

8.3



50

5

66-102

85

16.0

18.7

m/z 316 (confirmation ion 2)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

77-101

86

10.4

12.1



50

5

66-102

85

15.6

18.3

Surface Water

m/z 276 (quantitation ion)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

74-101

90

10.1

11.2



50

5

87-102

95

5.9

6.2

m/z 292 (confirmation ion 1)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

71-106

91

15.5

17.1



50

5

86-101

94

5.7

6.0

m/z 316 (confirmation ion 2)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

71-97

89

10.7

12.0



50

5

88-102

95

8.7

9.5

Data (uncorrected recoveries) obtained from Tables 1-12, pp. 30-40 of MRID 49385902.

1	Water matrices were fully characterized (pp. 13-16).

2	Ethalfluralin recovered ranged 1.160-1.323 ng/L, 1.360-1.466 ng/L and 1.154-1.345 ng/L in the drinking water,
ground water and surface water, respectively. The % recovery was reported as below the LOQ in the study report.

Page 5 of 11


-------
Ethalfluralin (PC 113101)

MRIDs 49385902 (ECM) 49385903 (ILV)

Table 3. Independent Validation Method Recoveries for Ethalfluralin in Water1

Analyte

Fortification

Number

Recovery

Mean

Standard

Relative Standard

Level (ng/L)

of Tests

Range (%)

Recovery (%)

Deviation (%)

Deviation (%)

Drinking Water

m/z 276 (quantitation ion)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

73-89

80

80

8



50

5

77-89

84

84

7

m/z 292 (confirmation ion 1)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

75-93

81

81

9



50

5

79-91

86

86

6

m/z 316 (confirmation ion 2)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

74-88

79

79

7



50

5

79-92

87

87

7

Surface Water

m/z 276 (quantitation ion)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

77-86

80

80

5



50

5

70-85

76

76

7

m/z 292 (confirmation ion 1)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

77-88

82

82

5



50

5

70-85

77

77

7

m/z 316 (confirmation ion 2)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

75-86

81

81

6



50

5

71-88

78

78

8

Ground Water

m/z 276 (quantitation ion)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

80-86

83

83

3



50

5

86-89

88

88

2

m/z 292 (confirmation ion 1)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

74-89

80

80

8



50

5

88-91

89

89

1

m/z 316 (confirmation ion 2)



1.5 (LOD)

1

	2

--

--

--

Ethalfluralin

5 (LOQ)

5

76-85

80

80

4



50

5

89-91

90

90

1

Data (uncorrected recoveries) obtained from Tables 1-18, pp. 24-35 of MRID 49385903.

1	Water matrices were fully characterized (p. 12).

2	Ethalfluralin recovered ranged 1.36-1.53 ng/L, 1.29-1.46 ng/L and 1.20-1.62 ng/L in the drinking water,
water and surface water, respectively. The % recovery was reported as below the LOQ in the study report.

ground

Page 6 of 11


-------
Ethalfluralin (PC 113101)

MRIDs 49385902 (ECM) 49385903 (ILV)

III. Method Characteristics

In the ECM and ILV, the LOQ and LOD were 5 ng/L and 1.5 ng/L, respectively (p. 26; Tables
14-16, pp. 41-42 of MRID 49385902; p. 11; Tables 1-18, pp. 24-35 of MRID 49385903). In the
ECM, the LOD was defined as the lowest analyte concentration detectable above the mean
amplitude of the background noise at the retention time of the analyte in the control samples. The
LOD values were estimated as three times the background noise. This value was noted to vary
between runs and instruments. LOQ values were estimated by the equation LOQ = LOD 0.3.
The results for the calculated LOD and LOQ values for each ion/matrix supported the designated
LOQ and LOD values for the method. The LOQ and LOD values of the ILV were based on the
ECM; the ILV justified the LOQ with the successful validation results of the ILV.

Table 4. Method Characteristics



Ethalfluralin



Drinking water Ground water Surface water

Limit of Quantitation (LOQ)

5 ng/L

Limit of Detection (LOD)

1.5 ng/L

Linearity (calibration curve
r2 and concentration
range)1,2

ECM

r2 = 0.9989 (m/z 276)
r2 = 0.9984 (m/z 292)
r2 = 0.9983 (m/z 316)

ILV

r2 = 0.9968 (m/z 276)
r2 = 0.9972 (m/z 292)
r2 = 0.9967 (m/z 316)

Cone, range

(0.75-100 ng/L orng/mL)

Repeatable

Yes

Reproducible

Yes

Specific

Yes3

Data were obtained from p. 26; Tables 14-16, pp. 41-42; Figures 1-3, pp. 43-45; Figures 5-7, pp. 47-49; Figures 9-
11, pp. 51-53; Figures 13-15, pp. 55-57 of MRID 49385902; p. 11; Tables 1-18, pp. 24-35; Figures 1-3, pp. 38-40;
Figures 6-8, pp. 43-45; Figures 12-14, pp. 49-51; Figures 18-20, pp. 55-57 of MRID 49385903.

1	Not matrix-specific.

2	ECM calibration curves were confirmed by the reviewer (r2 = 0.9979-0.9982) using data obtained from Figures 1-
3, pp. 43-45 of MRID 49385902 (see DER Attachment 2). ILV calibration curves were confirmed by the reviewer
(r2= 0.9974-0.9978) using data obtained from Figures 1-3, pp. 38-40 of MRID 49385903 (see DER Attachment 2).

3	The chromatograms depicting the analyte peaks and control matrices were displayed in the ECM and ILV Figures
with faint to light resolution. The chromatograms were decipherable, but not clearly readable with normal, expected
resolution.

IV. Method Deficiencies and Reviewer's Comments

1. The chromatograms depicting the analyte peaks and control matrices were displayed in
the ECM and ILV Figures with faint to light resolution. The chromatograms were
decipherable, but not clearly readable with normal, expected resolution. The reviewer
determined that there was no interference with the analyte peak based on the provided
chromatograms; however, the reviewer noted a margin of error in this evaluation based
on poor quality of resolution in the submitted chromatograms. In the ECM and ILV, the
study authors noted that there were no interferences present in the chromatograms of the

Page 7 of 11


-------
Ethalfluralin (PC 113101)

MRIDs 49385902 (ECM) 49385903 (ILV)

untreated control sample at the retention times of the analyte that were greater than 30%
of the LOQ (quantitative and confirmatory ions; p. 24 of MRID 49385902; p. 19 of
MRID 49385903).

2.	This ECM (MRID 49385902) was conducted to update the ChemService residue
analytical method number 19/2002, Garofani, S. 2003. "Determination of Ethalfluralin
Residues in Drinking, Ground and Surface waters by Gas Chromatography with Electron
Capture Detector" and achieve a lower limit of quantitation, 5.0 ng/L (p. 10 of MRID
49385902). ChemService residue analytical method number 19/2002 (ChemService
19/2002) was included as Appendix B, pp. 62-121 of MRID 49385902. The LOQ for
ChemService 19/2002 is 0.05 ng/L. Water samples were passed through a pre-
conditioned SPE CI8 cartridge, eluted with ethyl acetate, then analyzed using gas
chromatography with electron capture detection (GC/ECD; Appendix B, p. 72; Appendix
B, Appendix 1, pp. 92-95). The sample extraction procedure was similar to that of this
ECM; however, the initial sample volume and ethyl acetate elution volume differed. The
use of GC/MS was described for confirmation of ethalfluralin (Appendix B, p. 74;
Appendix B, Appendix 1, p. 101). The GC/MS column and chromatographic conditions
differed greatly from those of this ECM.

For ChemService residue analytical method number 19/2002, GC/ECD recovery results
of ethalfluralin in drinking water, ground water and surface water ranged 73-109%, 69-
108%) and 72-111%), respectively, for all fortification levels (LOQ, lOxLOQ, lOOxLOQ
and lOOOxLOQ, n = 6 for each fortification level; Appendix B, Tables 3-26, pp. 78-89;
Appendix B, Appendix 1, Tables 5-8, pp. 99-100 of MRID 49385902). The nominal
LOQ was 0.05 ng/L; however, the actual fortification rates for the LOQ and lOxLOQ
samples were 0.06 ng/L and 0.60 ng/L, respectively, in drinking and ground water. The
reviewer noted that the overall recovery range for ground water was reported as "70-
108%o" in the study report (Appendix B, p. 76; Appendix B, Appendix 1, Table 6, p. 99),
even though the recovery of Spike D5 was 68.54%) (Appendix B, Table 18, p. 85;
Appendix B, Appendix 1, Table 8, p. 100). This value was treated as an outlier in the
study report (Appendix B, Appendix 1, Table 6, p. 99). No GC/MS recovery results were
reported.

Representative GC/ECD and GC/MS chromatograms for ChemService residue analytical
method number 19/2002 were faint and/or difficult to interpret (Appendix B, Appendix 1,
Figures 1-9, pp. 103-111 of MRID 49385902).

3.	The determinations of the LOD and LOQ in the ECM and ILV were acceptable, based on
scientifically procedures as defined in 40 CFR Part 136. In the ECM, the LOD values
were estimated as three times the background noise (p. 26; Tables 14-16, pp. 41-42 of
MRID 49385902). This value was noted to vary between runs and instruments. LOQ
values were estimated by the equation LOQ = LOD 0.3. The results for the calculated
LOD and LOQ values for each ion/matrix supported the designated LOQ and LOD
values for the method. The LOQ and LOD values of the ILV were based on the ECM; the
ILV justified the LOQ with the successful validation results of the ILV (p. 11; Tables 1-
18, pp. 24-35 of MRID 49385903).

Page 8 of 11


-------
Ethalfluralin (PC 113101)

MRIDs 49385902 (ECM) 49385903 (ILV)

4.	In the ECM, the method directed the correction of sample recoveries for analyte
concentration in the control samples (p. 22 of MRID 49385902). Generally, since analyte
found in the controls was reported as "ND", the reviewer considered the ethalfluralin
samples to be uncorrected for matrix blanks; however, the reviewer noted that "ND" was
defined as "residue.. .below the 1.5 ng/L, the limit of detection", so the control values
were not necessarily valued at 0.000 ng/L (Tables 1-12, pp. 30-40). The calculations of
the ILV did not report the correction for background in the controls (pp. 17-18 of MRID
49385903).

5.	The matrix effects were assessed for each matrix in the ECM and ILV (Table 13, p. 40 of
MRID 49385902; Table 22, p. 37 of MRID 49385903). No significant suppression or
enhancement of the instrument (<20%) was observed for all ions monitored (p. 25 of
MRID 49385902; p. 19 of MRID 49385903).

6.	The storage stability of the final extracts were assessed in the ECM and ILV; the standard
solutions were also assessed in the ECM. In the ECM, the final extracts of the surface
water samples were found to be stable up to 7 days under refrigeration; however, those of
the ground and drinking water were not found to be stable (primary transition ion
measured; pp. 25-26; Tables 17-18, p. 42 of MRID 49385902). Based on this data, the
study author recommended that extracts are analyzed immediately. Mean recoveries were
65%, 65% and 87%, respectively, for the drinking water, ground water and surface water.
The standard solutions were found to be stable up to 11 days under refrigeration (primary
transition ion measured; standard curves were compared).

In the ILV, the final extracts were found to be stable at 4°C up to 8 days for the surface
and ground water samples and up to 10 days for the drinking water samples (primary and
confirmatory transition ions measured; pp. 19-20; Tables 19-21, pp. 36-37 of MRID
49385903). Mean recoveries and RSDs after storage were 80% and 5% (m/z 276) and
77%) and 6% (m/z 292), respectively, for the drinking water; 77% and 6% (m/z 276) and
77%) and 6%> (m/z 292), respectively, for the surface water; and 81%> and 3% (m/z 276)
and 80%) and 6% (m/z 292), respectively, for the ground water.

7.	No communication occurred between the ILV and ECM study directors (p. 21 of MRID
49385903).

8.	It was reported for the ILV that one set of thirteen samples required ca. four person hours
to complete (p. 20 of MRID 49385903). Subsequent GC/MS analysis was performed
unattended (14 hours). Evaluation of results required ca. three hours. The overall time
for a sample set was ca. 1.5 calendar days.

Page 9 of 11


-------
Ethalfluralin (PC 113101)

MRIDs 49385902 (ECM) 49385903 QLV)

V. References

U.S. Environmental Protection Agency. 2012. Ecological Effects Test Guidelines, OCSPP
850.6100, Environmental Chemistry Methods and Associated Independent Laboratory
Validation. Office of Chemical Safety and Pollution Prevention, Washington, DC. EPA
712-C-001.

40 CFR Part 136. Appendix B. Definition and Procedure for the Determination of the Method
Detection Limit-Revision 1.11, pp. 317-319.

Page 10 of 11


-------
Ethalfluralin (PC 113101)

MRIDs 49385902 (ECM) 49385903 QLV)

Attachment 1: Chemical Names and Structures
Ethalfluralin (pp. 61, 71 of MRID 49385902)

IUPAC Name: N-Ethyl-a, a, a-trifluoro-N-(2-methylallyl)-2,6-dinitro-£>-toluidine
CAS Name:	N-Ethyl-N-(2-methyl-2-propenyl)-2,6-dinitro-4-

(trifluoromethyl)benzamine
CAS Number: 55283-68-6

SMILES String: Not reported





Page 11 of 11


-------